Bacteria-phage infection network structure and genomic defence system content predict efficacy of a phage therapy cocktail against Pseudomonas aeruginosa from chronic lung infections (2025)
Attributed to:
Does CRISPR-Cas immunity limit the effectiveness of phage therapy?
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1098/rstb.2024.0080
Publication URI: http://dx.doi.org/10.1098/rstb.2024.0080
Type: Journal Article/Review
Parent Publication: Philosophical Transactions of the Royal Society B: Biological Sciences
Issue: 1934